(Q40855272)

24 September 2017

1 reference

title

A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS. (English)

1 reference

24 September 2017

1

Hilleman MR

1 reference

PubMed ID

9627935

24 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

24 September 2017

16

1 reference

inferred from page(s)

published in

Vaccine

1 reference

24 September 2017

16

1 reference

24 September 2017

8

1 reference

24 September 2017

778-793

1 reference

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Vaccine strategies: selective elicitation of cellular or humoral immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Immune responses during measles virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Changes within T cell receptor V beta subsets in infants following measles vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Mechanism of suppression of cell-mediated immunity by measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Regulation of apoptosis by viral gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Side reaction to measles vaccination suggesting the Arthus phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Revaccination of previous recipients of killed measles vaccine: clinical and immunologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Viral genetic variation: hepatitis B virus as a clinical example

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

To kill or to cure: options in host defense against viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

MHC class I-restricted CTL responses to exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Immunopathogenesis of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Researchers air alternative views on how HIV kills cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Th2 cell clonal anergy as a consequence of partial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Induction of Antigen-Specific Unresponsiveness with Synthetic Peptides: Specific Immunotherapy for Treatment of Allergic and Autoimmune Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Exploiting the HIV-chemokine nexus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Fighting HIV-1 with IL-16

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Evolution and plasticity of CTL responses against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Reexamining AIDS research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Overhauling AIDS research: views from the community

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Whether and when an AIDS vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

1 reference

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Mucosal immunization with DNA-liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Anti-HIV env immunities elicited by nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Development of improved vectors for DNA-based immunization and other gene therapy applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Development of a multicomponent candidate vaccine for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

HIV type 1 coreceptors, neutralization serotypes, and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900272-7

7 January 2021

10.1016/S0264-410X(97)00272-7

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9627935